We are live on ! Find out more
PG icon

Procter & Gamble

2,075 hedge funds and large institutions have $134B invested in Procter & Gamble in 2017 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 836 increasing their positions, 913 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 74

0.46% less ownership

Funds ownership: 60.69%60.23% (-0.46%)

1% less funds holding

Funds holding: 2,0872,075 (-12)

4% less capital invested

Capital invested by funds: $139B → $134B (-$5.05B)

8% less repeat investments, than reductions

Existing positions increased: 836 | Existing positions reduced: 913

14% less funds holding in top 10

Funds holding in top 10: 280241 (-39)

42% less call options, than puts

Call options by funds: $1.04B | Put options by funds: $1.78B

Holders
2,075
Holders Change
-12
Holders Change %
-0.57%
% of All Funds
51.72%
Holding in Top 10
241
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-13.93%
% of All Funds
6.01%
New
82
Increased
836
Reduced
913
Closed
74
Calls
$1.04B
Puts
$1.78B
Net Calls
-$737M
Net Calls Change
-$345M
Name Holding Trade Value Shares
Change
Change in
Stake
PFC
1126
Poplar Forest Capital
California
$2.55M
ACM
1127
Argyle Capital Management
Pennsylvania
$2.55M
FC
1128
Fayerweather Charles
$2.54M +$25.7K +291 +1%
SFSG
1129
Stearns Financial Services Group
North Carolina
$2.54M +$18.5K +210 +0.7%
WPP
1130
Whalerock Point Partners
Rhode Island
$2.54M +$94.9K +1,077 +4%
AMM
1131
American Money Management
California
$2.53M -$80K -908 -3%
SIP
1132
Stoneridge Investment Partners
Pennsylvania
$2.52M +$70.7K +802 +3%
KB
1133
Kimelman & Baird
New York
$2.51M
AIM
1134
Anchor Investment Management
South Carolina
$2.51M +$54K +613 +2%
SXL
1135
Summit X LLC
Missouri
$2.51M +$2.54M +28,776 New
AWCI
1136
Alpine Woods Capital Investors
New York
$2.5M +$44.1K +500 +2%
PRS
1137
Pinkerton Retirement Specialists
Idaho
$2.48M -$4.05K -46 -0.2%
VLKIM
1138
Van Lanschot Kempen Investment Management
Netherlands
$2.48M
Kovitz Investment Group Partners
1139
Kovitz Investment Group Partners
Illinois
$2.48M -$192K -2,175 -7%
PCM
1140
Palisade Capital Management
New Jersey
$2.48M -$112K -1,266 -4%
CCA
1141
Checchi Capital Advisers
California
$2.48M -$61.3K -695 -2%
CNC
1142
Citizens & Northern Corp
Pennsylvania
$2.48M -$604K -6,850 -19%
MNBTD
1143
Moody National Bank Trust Division
Texas
$2.48M -$2.2K -25 -0.1%
GXMC
1144
Global X Management Company
New York
$2.47M +$1.04M +11,742 +71%
SBSB
1145
Sullivan, Bruyette, Speros & Blaney
Virginia
$2.46M +$33.3K +378 +1%
PWAP
1146
Private Wealth Advisors (Pennsylvania)
Pennsylvania
$2.46M +$98.8K +1,121 +4%
SCA
1147
Snowden Capital Advisors
New York
$2.45M +$374K +4,247 +18%
PL
1148
Perpetual Ltd
Australia
$2.44M +$273K +3,100 +12%
ACM
1149
Alpha Capital Management
Texas
$2.44M -$43.3K -491 -2%
LOAME
1150
Lombard Odier Asset Management (Europe)
United Kingdom
$2.44M

PG Hedge Fund Activity: Q2 2017 in Review

2,075 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Procter & Gamble (PG) for Q2 2017, worth a combined $134B — down 3.6% from $139B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new PG positions and 74 closed out — a net gain of 8 holders — while 836 added to existing stakes and 913 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $465M. The largest seller was Bank of New York Mellon, cutting an estimated $499M.

  • 2,075 institutional investors held Procter & Gamble (PG) as of Q2 2017, down from 2,087 in Q1 2017.
  • Funds reported $134B of Procter & Gamble stock for Q2 2017, down 3.6% quarter-over-quarter.
  • 82 funds opened new Procter & Gamble positions in Q2 2017 and 74 closed out, a net change of +8 holders.
  • The largest Procter & Gamble buyer in Q2 2017 was Capital Research Global Investors, an estimated $465M added.
  • The largest Procter & Gamble seller in Q2 2017 was Bank of New York Mellon, an estimated $499M sold.

Based on aggregated 13F filings for Q2 2017.